“Reply to Comment by Arber C, Et Al. On: Real-World Expenditures and Survival Time After CAR-T Treatment for Large B-Cell Lymphoma in Switzerland”. Swiss Medical Weekly, vol. 154, no. 10, Oct. 2024, p. 3958, https://doi.org/10.57187/s.3958.